Page 53 - ஆரோக்கியம் ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A statement from the HPRA said: “To date, the HPRA has received a small number of reports associated with blood clots following vaccination with the AstraZeneca vaccine. “However, it has not received any reports of the nature of those described by the Norwegian Medicines Agency. “We will continue to monitor national reports very closely and continue to encourage the reporting of any suspected side effect following vaccination with a Covid-19 vaccine.” It said there was no indication that vaccination was the cause of these events and there may be alternative, unrelated explanations for their occurrence. (PA Graphics) The authority added: “However, the safety of the public is of the utmost importance, and it is essential that reports of potential safety concerns, even if very rare, are rigorously and swiftly investigated so that the public can be reassured and if required, appropriate action can be taken.”

Oxford covidRonan glynnEuropean medicines agencyNational immunisation office nio hseimm pa graphicsNorwegian medicines agencyHealth products regulatory authorityNorwegian medicinesImmunisation officeEuropean economicரோனன் க்ளின்ஆரோக்கியம் ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம்நோர்வே மருந்துகள்நோய்த்தடுப்பு அலுவலகம்ஐரோப்பிய பொருளாதார